Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas. (4th November 2015) - Crittenden, Marka; Bahjat, Keith S; Li, Rui; Gore, Pankaj; Fountain, Chris; Hanson, Bill; Skoble, Justin; Lauer, Peter; Murphy, Aimee L; Dubensky, Thomas; Brockstedt, Dirk G; Urba, Walter